Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing ProcessGlobeNewsWire • 07/27/26
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026GlobeNewsWire • 07/22/26
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M DealZacks Investment Research • 07/01/26
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®GlobeNewsWire • 07/01/26
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer BiometGlobeNewsWire • 06/30/26
Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual MeetingPRNewsWire • 06/09/26
Pacira BioSciences, Inc. (PCRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/08/26
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual MeetingPRNewsWire • 06/04/26
Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director NomineesPRNewsWire • 06/01/26
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira's Director NomineesGlobeNewsWire • 05/28/26
DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTIONPRNewsWire • 05/28/26
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified NomineesGlobeNewsWire • 05/27/26
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder ArthroplastyGlobeNewsWire • 05/27/26
Pacira BioSciences Sets the Record Straight Regarding DOMA's Misleading Statements About Pacira's Intellectual Property StrategyGlobeNewsWire • 05/26/26
PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in OntarioGlobeNewsWire • 05/25/26
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLCPRNewsWire • 05/21/26
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira BiosciencesPRNewsWire • 05/20/26
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All StockholdersGlobeNewsWire • 05/20/26
DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board CandidatesPRNewsWire • 05/13/26